Pharmacovigilance in epileptic patients using antiepileptic drugs

Arquivos de Neuro-Psiquiatria

Volumn 64, Issue 2 A, 2006, Pages 198-201

  Mei, Paulo Afonso ^a   Montenegro, Maria Augusta ^a   Guerreiro, Marilisa M ^a   Guerreiro, Carlos A M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Adverse events; Antiepileptic drugs; Depression; Epilepsy; Pharmacovigilance

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; AGED; AGGRESSIVENESS; ANXIETY DISORDER; APPETITE DISORDER; ARTHRALGIA; ARTICLE; BLURRED VISION; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CONCENTRATION LOSS; CONTROLLED STUDY; DEPRESSION; DIPLOPIA; DIZZINESS; DRUG SURVEILLANCE PROGRAM; DRUG USE; DYSPEPSIA; EMOTION; EPILEPSY; ERECTILE DYSFUNCTION; FATIGUE; FEMALE; GINGIVA BLEEDING; GINGIVA HYPERTROPHY; HAIR LOSS; HEADACHE; HIRSUTISM; HUMAN; IRRITABILITY; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL INSTABILITY; MONOTHERAPY; PATIENT SELECTION; QUESTIONNAIRE; RASH; RESTLESSNESS; SEMI STRUCTURED INTERVIEW; SIDE EFFECT; SKIN ALLERGY; SKIN MANIFESTATION; SLEEP DISORDER; SOMNOLENCE; TREMOR; UNSTEADINESS; WEIGHT GAIN;

EID: 33745519543     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2006000200005     Document Type: Article

References (33)

1. Mattson RH. Medical management of epilepsy in adults. Neurology 1998;51(Suppl 4):S15-S20.
2. Arroyo S, de la Morena A. Life-threatening adverse events of antiepileptic drugs. Epilepsy Res 2001;47:155-174.
3. Bazil CW. Sleep and epilepsy. Semin Neurol 2002;22:321-327.
4. Bruni J. Antiepileptic drug selection and adverse effects: an overview. Can J Neurol Sci 1994;21(Suppl):S3-S6.
5. Buchanan N. The occurrence, management and outcome of antiepileptic drug side effects in 767 patients. Seizure 1992;1:89-98.
6. Dodrill CB. Neuropsychological aspects of epilepsy. Psychiatr Clin N Am 1992;15:383-394.
7. Drane DL, Meador KJ. Epilepsy, anticonvulsant drugs and cognition. Baillieres Clin Neurol 1996;5:877-885.
8. Ferrendelli JA. Pharmacology of antiepileptic drug polypharmacy. Epilepsia 1999;40(Suppl 5):S81-S83.
9. Ferrendelli JA. Concerns with antiepileptic drug initiation: safety, tolerability, and efficacy. Epilepsia 2001;42(Suppl 4):S28-S30.
10. Greenwood RS. Adverse effects of antiepileptic drugs. Epilepsia 2000;41(Suppl 2):S42-S52.
11. Holland KD. Efficacy, pharmacology, and adverse effects of antiepileptic drugs. Neurol Clin 2001;19:313-345.
12. Jallon P, Picard F. Bodyweight gain and anticonvulsants: a comparative review. Drug Saf 2001;24:969-978.
13. Keyser A, Hekster YA, Termond E, Theeuwes A, Schaap M, Rwiza HT. Side-effects of drugs in epileptic patients. Pharm Weekbl Sci 1990;12:145-150.
14. Mattson RH. Efficacy and adverse effects of established and new antiepileptic drugs. Epilepsia 1995;36(Suppl 2):S13-S26.
15. Schlienger RG; Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998;39(Suppl 7):S3-S7.
16. Deckers CL. Place of polytherapy in the early treatment of epilepsy. CNS Drugs 2002;16:155-163.
17. Salas-Puig J. Rational anti-epileptic polytherapy: drug interactions and choice of treatment. Rev Neurol 2000;30:886-889.
18. Devinsky O. Cognitive and behavioral effects of antiepileptic drugs. Epilepsia 1995;36(Suppl 2):S46-S65.
19. Harden CL, Goldstein MA. Mood disorders in patients with epilepsy: epidemiology and management. CNS Drugs 2002;16:291-302.
20. Paciello N, Mazza M, Mazza S. Depression in epilepsy: symptom or syndrome?. Clin Ther 2002;153:397-402.
21. Schmitz B. Psychiatric syndromes related to antiepileptic drugs. Epilepsia 1999;40(Suppl 10):S65-S70.
22. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002;8(Suppl 5):S9-S20.
23. Radloff LS. The CES-D scale: a self report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385-401.
24. Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H. Systematic screening allows reduction of adverse antiepileptic drug effects. a randomized trial. Neurology 2004; 62:23-27.
25. Deckers CL, Hekster YA, Keyser A, et al. Reappraisal of polytherapy in epilepsy: a critical review of drug load and adverse effects. Epilepsia 1997;38:570-575.
26. Guberman A. Monotherapy or polytherapy for epilepsy? Can J Neurol Sci 1998;25(Suppl):S3-S8.
27. Lammers MW, Hekster YA, Keyser A, et al. Monotehrapy or polytherapy for epilepsy revisited: a quantitative assessment. Epilepsia 1995;36:440-446.
28. Isojavi JI, Tauboll E, Herzog AG. Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drugs 2005;19:207-223.
29. Yerby MS. Pregnancy, teratogenesis, and epilepsy. Neurol Clin 1994;12:749-771.
30. Caplan R, Siddarth P, Gurbani S, et al. Depression and anxiety disorders in pediatric epilepsy. Epilepsia 2005; 46:720-730.
31. Jackson MJ, Turkington D. Depression and anxiety in epilepsy. J Neurol Neurosurg Psychiatry 2005; 76 (Suppl 1):S45-S47.
32. Jones JE, Hermann BP, Woodard JL, et al. Screening for major depression in epilepsy with common self-report depression inventories. Epilepsia 2005;46:731-735.
33. Kanner AM. Depression in epilepsy: a frequently neglected multifaced disorder. Epilep Behav 2003; 4 (Suppl 4):S11-S19.